We have been informed by Indian Patent Office that our patent application no 201647039411, concerning our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes is being processed. We are awaiting for further decisions.
More technical details, concerning the patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology, have been published in the Data in Brief international journal (Data in Brief (2020) 28:105069).
The patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology, designed for the development of new generation vaccines, biologics, biosimilars, industrial and environmental was published in one of the top journals in the field – Materials Science & Engineering C (IF= 5). This publication shows in more detail the biotechnology described in the patents using legal language as well as adds more developments and is written in scientific language for readers convenience.